首页> 外文期刊>Advances in Infectious Diseases >The Association between Expression of NK Cells and Prognosis of Patients with HBV Acute-on-Chronic Liver Failure in Advanced Phase
【24h】

The Association between Expression of NK Cells and Prognosis of Patients with HBV Acute-on-Chronic Liver Failure in Advanced Phase

机译:高症阶段HBV急性对慢性肝衰竭患者NK细胞表达与预后的关联

获取原文
           

摘要

Acute-on-chronic liver failure (Acute-on-chronic liver failure, ACLF) is acute liver function decompensation on the basis of chronic liver disease. The progression of ACLF develops from advanced phase, plateau phase to remission phase. The pathophysiological basis of ACLF in different phases is various. In advanced phase, immune imbalance and systemic inflammatory reaction plays key roles. In this study, we try to assess the association between expression of NK cells and its receptors and prognosis of patients with ACLF in advanced phase. A total of 35 inpatients with HBV acute-on-chronic liver failure in advanced phase were recruited. They were divided into case group (n = 18) and control group (n = 17) according to whether the patients was dead in the 12 weeks. PBMC were detected for the frequency and expression of NK cell receptors by flow cytometric analysis. Our results demonstrated that patients who died had lower expression of NK cells and inhibitory receptor KIR3DL1, higher levels of FASL. During 12-week follow-up in those case alive, we found that NK cells increased, while expression of FASL decreased. High short-term mortality of ALCF was associated with NK cell, especially related to KIR3DL1 and FASL (PNK = 0.036, PKIR3DL1 = 0.0265, PFasL = 0.0008).
机译:急性慢性肝功能衰竭(急性慢性肝功能衰竭,ACLF)是在慢性肝病的基础上进行急性肝功能的失效。 ACLF的进展从高级阶段发展到缓解阶段。 ACLF在不同阶段的病理生理学基础是各种各样的。在高级阶段,免疫不平衡和全身炎症反应起到关键作用。在这项研究中,我们尝试评估NK细胞表达与其对ACLF患者在高级阶段的预后的关联。招募了在高级阶段的35例具有HBV急性急性肝功能衰竭的住院患者。根据患者在12周内是否死亡,它们分为案例组(n = 18)和对照组(n = 17)。通过流式细胞术分析检测NK细胞受体的频率和表达的PBMC。我们的结果表明,死亡的患者具有低表达NK细胞和抑制因子Kir3DL1,较高水平的FasL。在那些案例中的12周后续随访期间,我们发现NK细胞增加,而FASL的表达减少。 ALCF的高短期死亡率与NK细胞相关,特别是与Kir3DL1和FasL相关的( P NK = 0.036, P Kir3DL1 = 0.0265, p fasl = 0.0008)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号